CPHI&PMEC China 2024

Leading the Pharmaceutical Industry in a New Direction
A New Chapter in the Pharmaceutical Development

Exhibition Background

The 22nd World Pharmaceutical Ingredients China Exhibition and the 17th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition (CPHI & PMEC China 2024), China's leading event in the pharmaceutical industry chain, is set to open soon. The exhibition aims to establish a robust trade and exchange platform involving both domestic and international enterprises, striving to rejuvenate the industry and provide momentum for its development.

With a display area exceeding 210,000 square meters and over 3,500 renowned domestic and overseas exhibitors, the show anticipates attracting over 90,000 professional buyers from around the globe. Visitors from the pharmaceutical industry are expected to participate in the event, contributing to the recovery and prosperity of China's pharmaceutical sector.

Exhibition Time
19 -21 June

Exhibition Venue
Shanghai New International Expo Center

Morimatsu Booth
N3 C26

Bringing together pioneering ideas and fostering artisanal craftsmanship, Morimatsu will showcase innovative products and solutions at the International Zone of N3 Bioengineering Pavilion. We aim to share our research findings and cutting-edge technologies with the audience.

1.Solid Preparation Process Solution
Mini-MD Multi-functional Fluidized Bed
Experimental Wet Granulator

2.API Process solution
Solid Phase Peptide Synthesizer
Experimental WD Multifunctional Filtration and Washing Dryer

3. Total Laboratory Solutions
MOCELLULA™ WAV-2D Single-Use Bioreactor
MOCELLULA™ GBR/GFE Glass Bioreactor
MOCHROMA™ QBE Desktop Chromatography System
MOPURITY™ MUF-Lab Ultrafiltration System
Single-use system

Additionally, the exhibition will feature the Digital Intelligent Total Factory Solution and VR Simulation Training System, adding excitement to this pharmaceutical event.

Morimatsu sincerely invites you to visit our booth, explore the innovative path of the pharmaceutical industry with us, discover unlimited cooperation opportunities, promote internationalization and high-quality industrialization, and embark on a new chapter of development together.

About Morimatsu LifeSciences

Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Company Limited, Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services.

As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacturing plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.